Bifogade filer
PDF
Beskrivning
| Land | Finland |
|---|---|
| Lista | First North Finland |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Company release
Nanoform Finland Plc
December 18, 2024
17:01 Finnish time / 16:01 Swedish time
Nanoform Finland Plc - Manager's Transactions - Albert Hæggström
Helsinki, Finland - Manager's transaction related to Nanoform Finland Plc's Member of the Board and CFO Albert Hæggström's acceptance of stock options of Nanoform Finland Plc:
Nanoform Finland Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Albert Haeggström
Position: Chief Financial Officer
Issuer: Nanoform Finland Oyj
LEI: 743700JJO2NU8LBS1592
Notification type: INITIAL NOTIFICATION
Reference number: 88277/4/4
____________________________________________
Transaction date: 2024-12-17
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Nanoform Finland Oyj stock option 1/2025
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 120000 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 120000 Volume weighted average price: 0 EUR
For further information, please contact:
Henri von Haartman
Director of Investor Relations
+46 7686 650 11
About Nanoform
Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules' performance through its nanoforming technologies and formulation services, from pre-formulation to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform's shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Carnegie Investment Bank AB (publ), +46 8-588 68 570. For more information, please visit www.nanoform.com.